Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Healthy, Renal Impairment”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02098187
What this trial is testing

Pharmacokinetics of MP-3180 and Use of Noninvasive Fluorescence Detection Device in Healthy Volunteers

Who this might be right for
Glomerular Filtration RateAcute Kidney Injury
MediBeacon 16
Early research (Phase 1)Study completedNCT01318551
What this trial is testing

Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects

Who this might be right for
Anemia
Bayer 56
Not applicableNot Yet RecruitingNCT07494266
What this trial is testing

Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited Potassium Content in Patients With Chronic Kidney Disease: A Pilot Study

Who this might be right for
HyperkalemiaChronic Kidney Disease (Stages 4 and 5)
Karolinska Institutet 30
Testing effectiveness (Phase 2)Study completedNCT01588756
What this trial is testing

Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)

Who this might be right for
HealthyChronic Kidney Disease
Assistance Publique - Hôpitaux de Paris 100
Post-approval studies (Phase 4)Study completedNCT01043094
What this trial is testing

Safety, Tolerability, and Pharmacokinetic of Single Dose of Pitavastatin 4 mg in Severe Renal Patients Versus Healthy Adult Volunteers

Who this might be right for
Severe Renal Impairment
Kowa Research Institute, Inc. 16
Early research (Phase 1)Not Yet RecruitingNCT07557407
What this trial is testing

A Mass Balance Study of [14C]HRS-1780 in Healthy Adult Male Subjects

Who this might be right for
Chronic Kidney Diseases
Shandong Suncadia Medicine Co., Ltd. 6
Very early researchStudy completedNCT02998775
What this trial is testing

Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding

Who this might be right for
Hepatic Impairment; Renal Impairment
Eisai Inc. 54
Early research (Phase 1)Study completedNCT01240967
What this trial is testing

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Who this might be right for
Healthy VolunteersPatientsPharmacokinetics+1 more
AstraZeneca 40
Early research (Phase 1)Study completedNCT05495581
What this trial is testing

A Study About How ASP5354 Affects the Body in Healthy Adults and in Adults Whose Kidneys do Not Work Well

Who this might be right for
Healthy VolunteersRenal Impairment
Astellas Pharma Global Development, Inc. 28
Not applicableStudy completedNCT05565716
What this trial is testing

Supporting Self-Management of Healthy Behaviors in Diabetes, Kidney Disease, and Hypertension

Who this might be right for
Renal Insufficiency, ChronicHypertensionDiabetes
University of Pennsylvania 73
Early research (Phase 1)Ended earlyNCT03241147
What this trial is testing

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

Who this might be right for
Renal Failure
H. Lundbeck A/S 23
Early research (Phase 1)Study completedNCT06698549
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

Who this might be right for
COVID 19
Aligos Therapeutics 12
Early research (Phase 1)Looking for participantsNCT07615985
What this trial is testing

Phase 1a Study Assessing Safety, Tolerability, Pharmacokinetics, and Immunogenicity of PMG1016

Who this might be right for
Chronic Kidney Disease
Pulmongene Ltd. 30
Early research (Phase 1)Study completedNCT01613690
What this trial is testing

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 48
Early research (Phase 1)Study completedNCT04952506
What this trial is testing

Clinical Study to Compare the Pharmacokinetics and Safety of D113 With CKD-349 in Healthy Volunteers

Who this might be right for
Chronic Renal Failure
Chong Kun Dang Pharmaceutical 25
Early research (Phase 1)Looking for participantsNCT07024823
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Who this might be right for
Chronic Kidney Disease
AstraZeneca 124
Early research (Phase 1)Not Yet RecruitingNCT07797322
What this trial is testing

Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

Who this might be right for
Participants With Moderate and Severe Renal Impairment and Healthy Participants
Novartis Pharmaceuticals 40
Early research (Phase 1)Study completedNCT04324424
What this trial is testing

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers

Who this might be right for
Type 2 Diabetes Mellitus
Hua Medicine Limited 17
Early research (Phase 1)Study completedNCT04550234
What this trial is testing

A Study in Healthy Subjects to Assess Drug Availability of 4 Different Formulations of Verinurad and Allopurinol

Who this might be right for
Chronic Kidney Disease
AstraZeneca 25
Early research (Phase 1)Study completedNCT05515432
What this trial is testing

Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight

Who this might be right for
Chronic Kidney DiseaseRenal ImpairmentHealthy Volunteers
Bayer 45
Next Page